GERM vs. QDVO

Last updated Jun 4, 2026

GERM (Amplify Treatments, Testing and Advancements ETF) and QDVO (Amplify CWP Growth & Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while QDVO is a Derivative Income fund actively managed by Amplify. GERM is passively managed, while QDVO is actively managed. Over the past year, GERM returned 0.00% vs 27.43% for QDVO. GERM charges 0.68%/yr vs 0.56%/yr for QDVO.

Performance

GERM vs. QDVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify CWP Growth & Income ETF (QDVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

QDVO

• 1D: -0.55%
• 1M: 4.45%
• YTD: 9.80%
• 6M: 9.65%
• 1Y: 27.43%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. QDVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
QDVO Amplify CWP Growth & Income ETF	9.80%	20.16%	16.03%

GERM vs. QDVO - Sectors Allocation Comparison

Sectors	GERM	QDVO
Healthcare	99.3%	4.6%
Financial Services	0.4%	4.1%
Basic Materials	-	1.8%
Communication Services	-	16.8%
Consumer Cyclical	-	12.5%
Consumer Defensive	-	6.3%
Energy	-	0.8%
Industrials	-	1.7%
Real Estate	-	-
Technology	-	50.6%
Utilities	-	0.7%

Return for Risk

GERM vs. QDVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QDVO

QDVO Risk / Return Rank: 62
QDVO Sharpe Ratio Rank: 66
QDVO Sortino Ratio Rank: 65
QDVO Omega Ratio Rank: 64
QDVO Calmar Ratio Rank: 53
QDVO Martin Ratio Rank: 60

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. QDVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify CWP Growth & Income ETF (QDVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	GERM	QDVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.26	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	1.41	—

Drawdowns

GERM vs. QDVO - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum QDVO drawdown of -17.75%. Use the drawdown chart below to compare losses from any high point for GERM and QDVO.

Drawdown Indicators

	GERM	QDVO	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-17.75%	+17.75%
Max Drawdown (1Y) Largest decline over 1 year	0.00%	-10.21%	+10.21%
Current Drawdown Current decline from peak	0.00%	-0.94%	+0.94%
Average Drawdown Average peak-to-trough decline	0.00%	-2.37%	+2.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	2.51%	-2.51%

Volatility

GERM vs. QDVO - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify CWP Growth & Income ETF (QDVO) has a volatility of 2.89%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than QDVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GERM	QDVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	2.89%	-2.89%
Volatility (6M) Calculated over the trailing 6-month period	0.00%	8.87%	-8.87%
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	12.22%	-12.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	17.44%	-17.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	17.44%	-17.44%

GERM vs. QDVO - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than QDVO's 0.56% expense ratio.

Dividends

GERM vs. QDVO - Dividend Comparison

GERM has not paid dividends to shareholders, while QDVO's dividend yield for the trailing twelve months is around 10.12%.

Position	TTM	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
QDVO Amplify CWP Growth & Income ETF	10.12%	9.92%	2.79%

Frequently Asked Questions

Which is riskier, GERM or QDVO?

QDVO has higher volatility (2.89%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs QDVO's -17.75%.

Which ETF is better, GERM or QDVO?

On 1-year performance, QDVO leads with 27.43% vs 0.00% for GERM. On fees, QDVO is cheaper at 0.56% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, GERM or QDVO?

Over the 1-year period, QDVO has performed better with a 27.43% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, GERM or QDVO?

QDVO is cheaper with a 0.56% expense ratio, compared with 0.68% for GERM.

Which ETF pays a higher dividend yield, GERM or QDVO?

QDVO has the higher dividend yield at 10.12%, compared with 0.00% for GERM.

What is the main difference between GERM and QDVO?

GERM is categorized as Health & Biotech Equities, while QDVO is Derivative Income. Their fees differ too: 0.68% for GERM and 0.56% for QDVO.